查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1839267

新一代抗體療法市場分析及預測（至2034年）：類型、產品、技術、應用、製程、最終用戶、階段、部署、功能、模式

Next Generation Antibody Therapeutics Market Analysis and Forecast to 2034: Type, Product, Technology, Application, Process, End User, Stage, Deployment, Functionality, Mode
出版日期: | 出版商: Global Insight Services | 英文 336 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計新一代抗體療法市場將從2024年的36億美元成長到2034年的94億美元，複合年成長率約為10.1%。新一代抗體療法市場涵蓋旨在提高疾病治療特異性、療效和安全性的先進生物製藥，包括雙特異性抗體、抗體藥物複合體和工程化抗體片段。在分子工程創新和精準醫療的推動下，該市場預計將在腫瘤學、免疫學和感染疾病領域取得重大進展，滿足尚未滿足的醫療需求並拓展治療應用。

新一代抗體療法市場正經歷強勁成長，這主要得益於生技和精準醫療的進步。單株抗體因其在多種疾病標靶治療中的有效性而備受關注。雙特異性抗體具有雙重靶向能力，因其在癌症治療方面的潛力而日益受到重視，並成為成長第二快的細分市場。抗體藥物複合體）也正在崛起，成為重要的細分市場，它將抗體的特異性與強效細胞毒性藥物結合。腫瘤治療領域仍是成長最快的領域，反映出市場對創新癌症療法的旺盛需求。自體免疫疾病緊隨其後，受益於旨在調節免疫反應的新型抗體療法的開發。抗體工程和抗體生產技術的改進等技術進步正在推動市場成長。對個人化醫療的日益重視正在推動對客製化抗體療法的需求。製藥公司之間的策略合作與夥伴關係正在促進創新並拓展治療產品線。監管支持和快速核准流程進一步強化了市場活力，促進了新型抗體療法的上市。

市場區隔
類型 單株抗體、雙特異性抗體、抗體藥物複合體、抗體片段、多株多株抗體
產品 治療性抗體、診斷性抗體、研究性抗體、抗體片段
科技 噬菌體展示、融合瘤、基因轉殖小鼠、細菌展示、酵母展示、哺乳動物細胞展示
目的 腫瘤科、自體免疫疾病、感染疾病、心血管疾病、神經系統疾病、代謝性疾病
流程 發現、開發、生產、品管、監管核准
最終用戶 製藥公司、生技公司、研究機構、受託研究機構
步 臨床前試驗、臨床試驗與商業化
部署 內部、外包
功能 標靶治療、免疫療法、偶聯
模式 靜脈注射、皮下注射、肌肉注射、口服

市場概述

新一代抗體療法市場正經歷著劇烈的變革，創新企業推出的先進療法佔據了市場主導地位。定價策略競爭激烈，反映出市場對更有效、更具標靶性的治療方案的強勁需求。隨著各公司努力滿足未被滿足的醫療需求並提高治療效果，新產品上市數量迅速成長，市場呈現這樣的特徵。旨在加速產品開發和市場准入的策略聯盟和夥伴關係進一步加劇了這種競爭格局。在競爭基準化分析方面，主要企業不斷創新以保持競爭力。北美和歐洲嚴格的監管準則正在影響市場動態，其中監管因素發揮關鍵作用。監管環境正在不斷演變，旨在提高治療藥物開發的透明度和安全性。各公司正大力投資研發，以有效應對這些監管要求。隨著市場的不斷成熟，抗體工程和新型遞送平台的進步有望推動市場顯著成長，並為相關人員帶來豐厚的利潤機會。

主要趨勢和促進因素：

新一代抗體療法市場正經歷強勁成長，這主要得益於生技和個人化醫療的突破性進展。關鍵趨勢包括雙特異性抗體的開發，這種抗體能夠增強標靶能力和治療效果。抗體藥物複合體（ADC）的興起正在革新癌症治療，它能將細胞毒性藥物直接遞送至癌細胞，並最大限度地減少附帶損傷。用於治療自體免疫疾病的單株抗體也日益受到關注，這反映了市場對標靶治療的需求。推動市場成長的因素包括抗體工程技術的進步以及慢性病盛行率的不斷上升。監管核准的加快也有利於市場擴張。此外，生物技術公司與研究機構之間的合作正在促進創新並加速開發平臺。新興市場也蘊藏著大量機遇，這些市場擁有完善的醫療基礎設施，並且對先進療法的需求不斷成長。那些投資於強大的研發和策略夥伴關係的公司將更有利於掌握這些快速成長的機會。

限制與挑戰：

新一代抗體療法市場面臨許多重大限制和挑戰。其中一個主要限制因素是高昂的研發和生產成本，這對中小企業而言可能難以承受，並限制了其進入市場。這種經濟壁壘往往使市場力量集中在少數幾家大型公司手中，扼殺了創新。監管障礙也構成了巨大的挑戰。新療法的嚴格核准流程會延緩市場進入並增加成本。這種法規環境要求進行大量的臨床試驗，而這些試驗則耗時且耗力。抗體生產的複雜性也帶來了挑戰。生產這些療法需要先進的技術和專業知識，難以有效率地擴大生產規模。這種複雜性可能導致產品品質不穩定和供應鏈問題。來自傳統療法的競爭進一步阻礙了市場滲透。許多醫療服務提供者和患者仍然依賴現有治療方法，這減緩了新抗體藥物的普及。最後，智慧財產權和專利糾紛也會阻礙市場成長。圍繞專有技術的法律糾紛充斥著競爭激烈的市場環境，分散了研發資源。

關鍵人物

MacroGenics、ImmunoGen、MorphoSys、Genmab、Pieris Pharmaceuticals、AbCellera、Xencor、Adimab、MabSpace Biosciences、Harbor BioMed、Zymeworks、Bicycle Therapeutics、Crescendo Biologics、Mabion、I-Mab。

目錄

第1章新一代抗體療法市場概述

  • 調查目的
  • 新一代抗體療法市場定義和範圍
  • 報告局限性
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

第4章：新一代抗體療法市場展望

  • 新一代抗體療法市場區隔
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章新一代抗體療法市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀態
  • 供應鏈分析
  • 競爭產品分析
  • 最新進展

第6章：新一代抗體療法的市場規模

  • 以價值計算的新一代抗體療法市場規模
  • 新一代抗體療法市場規模（按銷售量計）

第7章新一代抗體療法市場（按類型分類）

  • 市場概覽
  • 單株抗體
  • 雙特異性抗體
  • 抗體藥物複合體
  • 抗體片段
  • 多株抗體
  • 其他

第8章新一代抗體療法市場：按產品分類

  • 市場概覽
  • 治療性抗體
  • 診斷抗體
  • 研究抗體
  • 抗體片段
  • 其他

第9章新一代抗體療法市場：依技術分類

  • 市場概覽
  • 噬菌體展示
  • 融合瘤
  • 基因改造小鼠
  • 細菌展示
  • 酵母展示
  • 哺乳動物細胞展示
  • 其他

第10章新一代抗體療法市場：按應用領域分類

  • 市場概覽
  • 腫瘤學
  • 自體免疫疾病
  • 感染疾病
  • 心血管疾病
  • 神經系統疾病
  • 代謝性疾病
  • 其他

第11章 依製程分類的新一代抗體療法市場

  • 市場概覽
  • 藥物發現
  • 發展
  • 製造業
  • 品管
  • 藥品核准
  • 其他

第12章新一代抗體療法市場（按最終用戶分類）

  • 市場概覽
  • 製藥公司
  • 生技公司
  • 研究所
  • 受託研究機構
  • 其他

第13章新一代抗體療法市場（按階段分類）

  • 市場概覽
  • 臨床前試驗
  • 臨床試驗
  • 商業化
  • 其他

第14章新一代抗體療法市場：依發展階段分類

  • 市場概覽
  • 內部
  • 外包
  • 其他

第15章新一代抗體療法市場：按功能分類

  • 市場概覽
  • 標靶治療
  • 免疫療法
  • 共軛
  • 其他

第16章新一代抗體療法市場（按模式分類）

  • 市場概覽
  • 靜脈注射
  • 皮下注射
  • 肌肉內注射
  • 口服
  • 其他

第17章新一代抗體療法市場（按地區分類）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章 競爭格局

  • 概述
  • 市佔率分析
  • 主要企業的定位
  • 衝突領導力圖譜
  • 供應商基準化分析
  • 發展策略基準化分析

第19章：公司簡介

  • MacroGenics
  • ImmunoGen
  • MorphoSys
  • Genmab
  • Pieris Pharmaceuticals
  • AbCellera
  • Xencor
  • Adimab
  • MabSpace Biosciences
  • Harbour BioMed
  • Zymeworks
  • Bicycle Therapeutics
  • Crescendo Biologics
  • Mabion
  • I-Mab
簡介目錄
Product Code: GIS34082

Next Generation Antibody Therapeutics Market is anticipated to expand from $3.6 billion in 2024 to $9.4 billion by 2034, growing at a CAGR of approximately 10.1%. The Next Generation Antibody Therapeutics Market encompasses advanced biologic drugs engineered to enhance specificity, efficacy, and safety in treating diseases. This includes bispecific antibodies, antibody-drug conjugates, and engineered antibody fragments. Driven by innovations in molecular engineering and a focus on precision medicine, this market promises significant advancements in oncology, immunology, and infectious diseases, addressing unmet medical needs and expanding therapeutic applications.

The Next Generation Antibody Therapeutics Market is experiencing robust growth, propelled by advancements in biotechnology and precision medicine. Monoclonal antibodies lead the market, driven by their efficacy in targeted therapies for various diseases. Bispecific antibodies, offering dual-targeting capabilities, are the second-highest performing sub-segment, gaining traction for their potential in oncology treatments. Antibody-drug conjugates are also emerging as a critical segment, combining antibody specificity with potent cytotoxic agents. The oncology therapeutic area remains the top-performing segment, reflecting the high demand for innovative cancer treatments. Autoimmune diseases follow, benefiting from the development of novel antibody therapies aimed at modulating immune responses. Technological advancements, such as improved antibody engineering and production techniques, are accelerating market growth. The increasing focus on personalized medicine is driving demand for tailored antibody therapies. Strategic collaborations and partnerships among pharmaceutical companies are fostering innovation and expanding the therapeutic pipeline. Regulatory support and expedited approval processes further enhance market dynamics, facilitating the introduction of novel antibody therapeutics.

Market Segmentation
TypeMonoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Antibody Fragments, Polyclonal Antibodies
ProductTherapeutic Antibodies, Diagnostic Antibodies, Research Antibodies, Antibody Fragments
TechnologyPhage Display, Hybridoma, Transgenic Mouse, Bacterial Display, Yeast Display, Mammalian Cell Display
ApplicationOncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases
ProcessDiscovery, Development, Manufacturing, Quality Control, Regulatory Approval
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations
StagePreclinical, Clinical Trials, Commercialized
DeploymentIn-House, Outsourced
FunctionalityTargeted Therapy, Immunotherapy, Conjugation
ModeIntravenous, Subcutaneous, Intramuscular, Oral

Market Snapshot:

Next Generation Antibody Therapeutics Market is witnessing a dynamic shift, with market share being dominated by innovative companies launching advanced therapeutics. Pricing strategies remain competitive, reflecting the high demand for more effective and targeted treatments. The market is characterized by a surge in new product launches, as companies strive to address unmet medical needs and enhance therapeutic efficacy. This competitive landscape is further invigorated by strategic collaborations and partnerships that aim to accelerate product development and market entry. In terms of competition benchmarking, key players are continuously innovating to maintain their competitive edge. Regulatory influences play a significant role, with stringent guidelines in North America and Europe impacting market dynamics. The regulatory landscape is evolving, encouraging transparency and safety in therapeutic development. Companies are investing heavily in research and development to navigate these regulations effectively. As the market continues to mature, advancements in antibody engineering and novel delivery platforms are expected to drive substantial growth, offering lucrative opportunities for stakeholders.

Geographical Overview:

The Next Generation Antibody Therapeutics Market is witnessing robust growth across various regions, each presenting unique opportunities. North America leads the market, propelled by substantial investments in biotechnology and a strong focus on innovative therapeutic solutions. The presence of major pharmaceutical companies and research institutions further bolsters the region's market dominance. Europe follows closely, with significant government support for biotechnological research and a well-established healthcare infrastructure. The region's emphasis on personalized medicine and advanced therapeutics enhances its market potential. In Asia Pacific, the market is expanding rapidly, driven by increasing healthcare expenditure and a growing focus on precision medicine. Countries like China and India are emerging as key players, with rising investments in biopharmaceutical research and development. Latin America and the Middle East & Africa are burgeoning markets with increasing potential. Brazil and Saudi Arabia are witnessing a surge in biotechnology investments, recognizing the importance of next-generation antibody therapeutics in advancing healthcare outcomes.

Key Trends and Drivers:

The Next Generation Antibody Therapeutics Market is experiencing robust growth driven by breakthroughs in biotechnology and personalized medicine. Key trends include the development of bispecific antibodies, which enhance targeting capabilities and therapeutic efficacy. The rise of antibody-drug conjugates (ADCs) is revolutionizing cancer treatment by delivering cytotoxic agents directly to cancer cells, minimizing collateral damage. The market is also witnessing an increased focus on monoclonal antibodies for autoimmune diseases, reflecting the demand for targeted therapies. Drivers include technological advancements in antibody engineering and a growing prevalence of chronic diseases. Regulatory approvals are accelerating, providing a favorable landscape for market expansion. Moreover, collaborations between biotech firms and research institutions are fostering innovation and expediting the development pipeline. Opportunities abound in emerging markets, where healthcare infrastructure is improving, and demand for advanced therapeutics is rising. Companies investing in robust R&D and strategic partnerships are well-positioned to capitalize on these burgeoning opportunities.

Restraints and Challenges:

The Next Generation Antibody Therapeutics Market is confronted with several significant restraints and challenges. One primary restraint is the high cost of development and production, which can be prohibitive for smaller companies and limit market entry. This financial barrier often results in a concentration of market power among a few large players, stifling innovation. Regulatory hurdles present another formidable challenge. The stringent approval processes for new therapeutics can delay market entry and increase costs. This regulatory environment demands extensive clinical trials, which are both time-consuming and expensive. The complexity of antibody production also poses a challenge. Manufacturing these therapeutics requires advanced technology and expertise, which can be difficult to scale efficiently. This complexity can lead to variability in product quality and supply chain issues. Market penetration is further hindered by competition from traditional therapies. Many healthcare providers and patients remain loyal to established treatments, slowing the adoption of new antibody therapeutics. Lastly, intellectual property and patent disputes can impede market growth. The competitive landscape is fraught with legal battles over proprietary technologies, diverting resources from research and development.

Key Players:

MacroGenics, ImmunoGen, MorphoSys, Genmab, Pieris Pharmaceuticals, AbCellera, Xencor, Adimab, MabSpace Biosciences, Harbour BioMed, Zymeworks, Bicycle Therapeutics, Crescendo Biologics, Mabion, I-Mab

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Next Generation Antibody Therapeutics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Next Generation Antibody Therapeutics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by Process
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Stage
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Functionality
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by Process
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Stage
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Functionality
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Next Generation Antibody Therapeutics Market Outlook

  • 4.1 Next Generation Antibody Therapeutics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Next Generation Antibody Therapeutics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Next Generation Antibody Therapeutics Market Size

  • 6.1 Next Generation Antibody Therapeutics Market Size, by Value
  • 6.2 Next Generation Antibody Therapeutics Market Size, by Volume

7: Next Generation Antibody Therapeutics Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Bispecific Antibodies
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Antibody-Drug Conjugates
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Antibody Fragments
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Polyclonal Antibodies
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Others
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region

8: Next Generation Antibody Therapeutics Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Diagnostic Antibodies
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Research Antibodies
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Antibody Fragments
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Next Generation Antibody Therapeutics Market, by Technology

  • 9.1 Market Overview
  • 9.2 Phage Display
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Hybridoma
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Transgenic Mouse
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Bacterial Display
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Yeast Display
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Mammalian Cell Display
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Next Generation Antibody Therapeutics Market, by Application

  • 10.1 Market Overview
  • 10.2 Oncology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Autoimmune Diseases
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Infectious Diseases
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Cardiovascular Diseases
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Neurological Diseases
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Metabolic Diseases
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Next Generation Antibody Therapeutics Market, by Process

  • 11.1 Market Overview
  • 11.2 Discovery
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Development
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Manufacturing
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Quality Control
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Regulatory Approval
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Next Generation Antibody Therapeutics Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Contract Research Organizations
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Next Generation Antibody Therapeutics Market, by Stage

  • 13.1 Market Overview
  • 13.2 Preclinical
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Clinical Trials
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Commercialized
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Next Generation Antibody Therapeutics Market, by Deployment

  • 14.1 Market Overview
  • 14.2 In-House
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Outsourced
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Next Generation Antibody Therapeutics Market, by Functionality

  • 15.1 Market Overview
  • 15.2 Targeted Therapy
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Immunotherapy
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Conjugation
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Next Generation Antibody Therapeutics Market, by Mode

  • 16.1 Market Overview
  • 16.2 Intravenous
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Subcutaneous
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Intramuscular
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Oral
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region
  • 16.6 Others
    • 16.6.1 Key Market Trends & Opportunity Analysis
    • 16.6.2 Market Size and Forecast, by Region

17: Next Generation Antibody Therapeutics Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by Process
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Stage
    • 17.2.9 North America Market Size and Forecast, by Deployment
    • 17.2.10 North America Market Size and Forecast, by Functionality
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by Process
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Stage
      • 17.2.9.8 United States Market Size and Forecast, by Deployment
      • 17.2.9.9 United States Market Size and Forecast, by Functionality
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by Process
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Stage
      • 17.2.10.8 Canada Market Size and Forecast, by Deployment
      • 17.2.10.9 Canada Market Size and Forecast, by Functionality
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by Process
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Stage
    • 17.3.9 Europe Market Size and Forecast, by Deployment
    • 17.3.10 Europe Market Size and Forecast, by Functionality
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by Process
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Stage
      • 17.3.10.8 Germany Market Size and Forecast, by Deployment
      • 17.3.10.9 Germany Market Size and Forecast, by Functionality
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by Process
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Stage
      • 17.3.11.8 France Market Size and Forecast, by Deployment
      • 17.3.11.9 France Market Size and Forecast, by Functionality
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by Process
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Stage
      • 17.3.12.8 Spain Market Size and Forecast, by Deployment
      • 17.3.12.9 Spain Market Size and Forecast, by Functionality
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by Process
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Stage
      • 17.3.13.8 Italy Market Size and Forecast, by Deployment
      • 17.3.13.9 Italy Market Size and Forecast, by Functionality
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by Process
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.9 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by Process
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Stage
      • 17.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.9 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by Process
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.9 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by Process
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Stage
      • 17.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.9 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by Process
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Stage
      • 17.3.18.8 Finland Market Size and Forecast, by Deployment
      • 17.3.18.9 Finland Market Size and Forecast, by Functionality
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by Process
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Stage
      • 17.3.19.8 Russia Market Size and Forecast, by Deployment
      • 17.3.19.9 Russia Market Size and Forecast, by Functionality
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by Process
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Stage
      • 17.4.9.8 China Market Size and Forecast, by Deployment
      • 17.4.9.9 China Market Size and Forecast, by Functionality
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by Process
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Stage
      • 17.4.10.8 India Market Size and Forecast, by Deployment
      • 17.4.10.9 India Market Size and Forecast, by Functionality
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by Process
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Stage
      • 17.4.11.8 Japan Market Size and Forecast, by Deployment
      • 17.4.11.9 Japan Market Size and Forecast, by Functionality
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by Process
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Stage
      • 17.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.9 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by Process
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Stage
      • 17.4.13.8 Australia Market Size and Forecast, by Deployment
      • 17.4.13.9 Australia Market Size and Forecast, by Functionality
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by Process
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Stage
      • 17.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.9 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by Process
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.9 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by Process
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.9 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by Process
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.9 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by Process
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Stage
    • 17.5.9 Latin America Market Size and Forecast, by Deployment
    • 17.5.10 Latin America Market Size and Forecast, by Functionality
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by Process
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Stage
      • 17.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.9 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by Process
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Stage
      • 17.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.9 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by Process
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Stage
      • 17.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.9 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by Process
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Stage
      • 17.6.10.8 UAE Market Size and Forecast, by Deployment
      • 17.6.10.9 UAE Market Size and Forecast, by Functionality
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by Process
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Stage
      • 17.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.9 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 MacroGenics
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 ImmunoGen
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 MorphoSys
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Genmab
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Pieris Pharmaceuticals
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 AbCellera
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Xencor
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Adimab
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 MabSpace Biosciences
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Harbour BioMed
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Zymeworks
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Bicycle Therapeutics
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Crescendo Biologics
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Mabion
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 I-Mab
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis